Cardinal Health Inc. (CAH)
Cardinal Health Lifts Outlook Again as Revenue Rises
Cardinal Health once again raised its full-year outlook after logging higher-than-expected adjusted earnings in the third quarter.
William Blair Initiates Cardinal Health at Outperform: Is the Pharma Distributor a Stealth Compounder?
William Blair launched coverage of Cardinal Health (NYSE:CAH | CAH Price Prediction) with an Outperform rating today, framing the pharma distributor as a durable franchise with specialty-led upside.
Ahead of Cardinal (CAH) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Cardinal (CAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2026.
Cardinal Health Pre-Q3 Analysis: Buy, Hold or Sell the Stock Now?
CAH's Q3 results are likely to benefit from strong specialty momentum and GMPD progress, but tougher comps and tariff pressures may test upside.
Abacus FCF Advisors LLC Buys New Position in Cardinal Health, Inc. $CAH
Abacus FCF Advisors LLC purchased a new position in Cardinal Health, Inc. (NYSE: CAH) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 34,950 shares of the company's stock, valued at approximately $7,182,000. Other large investors have also added
Cardinal Health (CAH) Reports Next Week: Wall Street Expects Earnings Growth
Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
In the closing of the recent trading day, Cardinal Health (CAH) stood at $200.55, denoting a -2.13% move from the preceding trading day.
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note
Cardinal Health (CAH) reached $204.92 at the closing of the latest trading day, reflecting a -2.96% change compared to its last close.
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors
In the latest trading session, Cardinal Health (CAH) closed at $211.83, marking a -1.45% move from the previous day.
Wall Street Bulls Look Optimistic About Cardinal (CAH): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
